C. Kemp

发表

Mass Spectroscopic Characterization of the Coronavirus Infectious Bronchitis Virus Nucleoprotein and Elucidation of the Role of Phosphorylation in RNA Binding by Using Surface Plasmon Resonance

J. Hiscox, Hongying Chen, B. Dove, 2005, Journal of Virology.

A structural basis for the inhibition of collagen‐stimulated platelet function by quercetin and structurally related flavonoids

J. Lovegrove, A. Crozier, W. Mullen, 2010, British journal of pharmacology.

Titin‐cap associates with, and regulates secretion of, Myostatin

K. Patel, B. Langley, C. Kemp, 2002, Journal of cellular physiology.

Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.

C. Kemp, P. G. Knight, C. Glister, 2004, Reproduction.

Optimizing layer-by-layer deposition of interpolymer complexes on solid substrates using Biacore

V. Khutoryanskiy, Adrian C. Williams, C. Kemp, 2012 .

Emerging molecular targets for the treatment of pre-eclampsia

C. Kemp, P. Lowry, N. Page, 2001, Expert opinion on therapeutic targets.

The corticotrophin-releasing factor-binding protein: an act of several parts

C. Kemp, P. Lowry, R. Woods, 1998, Peptides.

Detection of N-terminal pro-corticotrophin releasing hormone (CRH) and a 'novel' CRH in human maternal plasma and placenta.

C. Kemp, P. Lowry, R. Woods, 2000, Placenta.

Cleavage of recombinant human corticotropin-releasing factor (CRF)-binding protein produces a 27-kilodalton fragment capable of binding CRF.

C. Kemp, I. Sumner, J. David, 1999, The Journal of clinical endocrinology and metabolism.

Heterogeneity of the human corticotropin-releasing factor-binding protein.

C. Kemp, J. David, P. Lowry, 1997, The Journal of clinical endocrinology and metabolism.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

C. Kemp, 1998 .

Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.

E. Jones, A. Hassan, C. Kemp, 2006, Journal of molecular biology.

Placental peptides as markers of gestational disease.

C. Kemp, P. Lowry, N. Page, 2002, Reproduction.

Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis.

K. Patel, I. McKinnell, C. Kemp, 2004, Developmental biology.

Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth.

K. Patel, C. Kemp, B. Christ, 2002, Developmental biology.

Nutrition Abstracts and Reviews Series B: Livestock Feeds and Feeding Safety issues associated with the DNA in animal feed derived from genetically modified crops. A review of scientific and regulatory procedures

C. Kemp, D. Beever, 2000 .

A randomized trial and novel SPR technique identifies altered lipoprotein-LDL receptor binding as a mechanism underlying elevated LDL-cholesterol in APOE4s

A. Minihane, J. Lovegrove, D. Leake, 2017, Scientific Reports.